skip to content

News & Articles

Full Transcript: Lindsay Avner, Founder and CEO of Bright Pink, on Sequenced

Linda Jiang

On this episode of Sequenced, we talk to Lindsay Avner, Founder and CEO of Bright Pink. Lindsay underwent genetic testing at age 22. The test revealed she carried a mutation on the BRCA1 gene. At 23, she became the youngest woman in the U.S. to undergo a risk-reducing double mastectomy. Lindsay shares her commitment to live proactively, why she founded Bright Pink, and how women can be advocates for their own health.

We’ve posted complete transcript of the podcast below. You can subscribe to Sequenced on Apple Podcasts, SoundCloud, Stitcher, and Google Play.

Bright Pink is a national non-profit organization that focuses on saving women’s lives from breast and ovarian cancer by empowering them to live proactively at a young age. Bright Pink offers interactive digital tools to help women assess their risk for breast and ovarian cancer (assessyourrisk.org) and address their questions around genetic testing (exploreyourgenetics.org).

Header image for JP Morgan 2022 Blog Post

Color takeaways from the J.P. Morgan Health Care Conference 2022

Meet Catherine Lacavera, Color’s new Chief Legal Officer

Color makes public health happen where public life happens

Image for blog post Color makes public health happen where public life happens

Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure